| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |